Merck to buy drug developer Pandion Therapeutics for $1.85 billion
(Reuters) - Merck & Co Inc said on Thursday it would buy drug developer Pandion Therapeutics Inc for about $1.85 billion in cash, to expand its portfolio of drugs that target autoimmune diseases.
